Читайте интересные истории, репортажи, интервью и обзоры в разделе "Новости".

Welcome to the world of online casinos! If you are looking for an exciting and thrilling gaming experience, then look no further than kasinoslovensko10.com. As one of the leading online casino platforms in Slovakia, we strive to provide our players with the best possible gaming options and an unforgettable adventure. At kasinoslovensko10.com, we understand the importance of constantly evolving and bringing new and innovative features to our players. That is why we are excited to introduce our newest addition - nové online casino. This state-of-the-art casino brings together the best of technology, design, and gameplay to create an immersive and captivating experience for our players. With nové online casino, you can expect a wide range of games to choose from. Whether you are a fan of classic table games like blackjack and roulette or prefer the thrill of video slots, nové online casino has it all. Our games are developed by some of the most renowned software providers in the industry, ensuring top-notch graphics, smooth gameplay, and fair outcomes. But that's not all! Nové online casino also offers a variety of exciting promotions and bonuses to enhance your gaming experience. From welcome bonuses to free spins and cashback offers, there is always something to look forward to at nové online casino. We understand that security and privacy are of utmost importance when it comes to online gaming. That is why we have implemented the latest encryption technology to ensure that your personal and financial information is always safe and secure. So, what are you waiting for? Join us at kasinoslovensko10.com and experience the thrill of nové online casino. With its cutting-edge features, extensive game selection, and generous bonuses, nové online casino is sure to become your new favorite gaming destination. Don't miss out on the opportunity to be a part of this exciting journey. Visit us today and let the games begin!

Macular degeneration

Macular degeneration, also known as Age-related macular degeneration (AMD), is an eye disease which is the leading cause of severe, irreversible vision impairment in developed countries.1,2 This eye disease is caused by a disorder of the macula, a part of the retina at the back of the eye, that has a very high concentration of photoreceptor cells, which sends signals to the brain in order to interpret those signals as images.

Some studies have shown that 8.7% of the worldwide population has age-related macular degeneration, and the projected number of people with the disease is around 288 million in 2040.3 Furthermore, other studies have suggested substantial racial or ethnic differences in disease prevalence.3,4,5

REFERENCES

1 Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020). Age-related macular degeneration preferred practice pattern®. Ophthalmology127(1), P1–P65.

2 World report on vision. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.

3 Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet. Global Health2(2), e106-16.

4Klein, R., Klein, B. E. K., Knudtson, M. D., Wong, T. Y., Cotch, M. F., Liu, K., … Jacobs, D. R., Jr. (2006). Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology113(3), 373–380.

5 Klein, R., Chou, C.-F., Klein, B. E. K., Zhang, X., Meuer, S. M., & Saaddine, J. B. (2011). Prevalence of age-related macular degeneration in the US population. Archives of Ophthalmology129(1), 75–80.

Age-related macular degeneration. (2021). Nature Reviews. Disease Primers7(1), 32.

Zouache, M. A., Bennion, A., Hageman, J. L., Pappas, C., Richards, B. T., & Hageman, G. S. (2020). Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10. Scientific Reports10(1), 21093.

Tan, A. C. S., Pilgrim, M. G., Fearn, S., Bertazzo, S., Tsolaki, E., Morrell, A. P., … Curcio, C. A. (2018). Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration. Science Translational Medicine10(466), eaat4544.

Colijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., … Zwiener, I. (2017). Prevalence of age-related macular degeneration in Europe. Ophthalmology124(12), 1753–1763.

Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013). Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Investigative Ophthalmology & Visual Science54(14), ORSF68-80.

Murdaugh, L. S., Wang, Z., Del Priore, L. V., Dillon, J., & Gaillard, E. R. (2010). Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch’s membrane. Experimental Eye Research90(5), 564–571.

Jager, R. D., Mieler, W. F., & Miller, J. W. (2008). Age-related macular degeneration. The New England Journal of Medicine358(24), 2606–2617.

Birch, D. G., & Liang, F. Q. (2007). Age-related macular degeneration: a target for nanotechnology derived medicines. International Journal of Nanomedicine2(1), 65–77.

Margrain, T. H., Boulton, M., Marshall, J., & Sliney, D. H. (2004). Do blue light filters confer protection against age-related macular degeneration? Progress in Retinal and Eye Research23(5), 523–531.

Schraermeyer, U., & Heimann, K. (1999). Current understanding on the role of retinal pigment epithelium and its pigmentation. Pigment Cell Research12(4), 219–236.

Kielbassa, C., Roza, L., & Epe, B. (1997). Wavelength dependence of oxidative DNA damage induced by UV and visible light. Carcinogenesis18(4), 811–816.

Gaillard, E. R., Atherton, S. J., Eldred, G., & Dillon, J. (1995). Photophysical studies on human retinal lipofuscin. Photochemistry and Photobiology61(5), 448–453.

Rózanowska, M., Jarvis-Evans, J., Korytowski, W., Boulton, M. E., Burke, J. M., & Sarna, T. (1995). Blue light-induced reactivity of retinal age pigment: In vitro generation of oxygen-reactive species. The Journal of Biological Chemistry270(32), 18825–18830.

Weiter, J. J., Delori, F. C., Wing, G. L., & Fitch, K. A. (1986). Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Investigative ophthalmology & visual science27(2), 145–152.

  • The World Family Macular Degeneration Center at OHSU Casey Eve
  • Wilmer Eye Institute – Jhons Hopkins Medicine
  • Harvard Medical School, Department of Ophthalmology
  • The University of British Columbia, Department of Ophthalmology and Virtual Sciences
  • Macular Research Group of Cardiff University
  • The New York Stem Cell Foundation
  • Scheie Eye Institute, University of Pennsylvania
  • BrightFocus Foundation

Despite the fact that are some studies in which the females seem to be more affected by the hypertrophic scars, probably reflecting the greater frequency of earlobe piercing among females1, in general, the researchers reach to the conclusion that men and women are similarly affected.2

REFERENCES

1 Udo-Affah, G. U., Eru, E. M., Idika, C. I., Uruakpa, K. C., & Njoku, C. C. (2014). The Age and Sex Incidence of Keloids/Hypertrophic Scars in Calabar Metropolis, Cross River State from 2001-2006. Age4(11).

2El Kinani, M., & Duteille, F. (2020). Scar epidemiology and consequences. Textbook on Scar Management (pp. 45–49). Cham: Springer International Publishing.

  • Approximately 8.7% of the total global blindness is attributed to AMD
  • The risk of getting AMD increase from 2% to 30% from the middle-aged people to the people over 75 years.
  • The Dry AMD makes up for about 90% of the total cases.
  • The Wet AMD is held responsible for only about 10% of the cases but it’s responsible for the highest number of legal blindness cases.
  • The disease is most common among older white people.
  • Risk factors:
    • Smoking
    • Dietary intake
    • Obesity
    • Hypertension
    • Sunlight exposure
    • Age
    • Gender
    • Race
    • Iris Colour
    • Genetics